Baltimore—Patient advocacy organizations expressed concern about copay programs and other payor trends that could have devastating clinical and financial effects, during a panel discussion at CBI’s Patient Assistance and Access Programs 2019 conference.
Over the past several years, some of the larger pharmacy benefit managers and commercial health plans have launched such programs, which do not count monies from manufacturer-sponsored copay cards or patient assistance